Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Male Patients With Lower Urinary Tract Syndrome

Phase 3

Completed

• Conditions: Urinary Tract Diseases

• Registration Number: NCT00239317
• Lead Sponsor: Astellas Pharma Inc

Brief Summary

The purpose of this study is to determine whether Tamusulosin is effective in the treatment of lower urinary tract syndrome with male patients.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2005-09-19
• Study First Submitted QC: 2005-10-13
• Study First Posted: 2005-10-17
• Status Verified: 2007-10
• Last Update Submitted: 2007-10-18
• Last Update Posted: 2007-10-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

• Patients with urination disorder not accompanied by apparent organic or neurologic abnormality(lower urinary tract syndrome: LUTs).

Read More

Exclusion Criteria

• Patients with urination disorder accompanied by apparent organic(benign prostatic hyperplasia: BPH) or neurologic abnormality, active urinary tract infections, severe cardiovascular, hepatic and/or kidney complications.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL